Valerie Jeanne Bardou

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. ncbi [Impact on the quality of pathology reports in the R2c cancer network: analysis of 4521 pathology reports of primary breast tumors]
    Valerie Jeanne Bardou
    Département d information médicale et biostatistique, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13273 Marseille Cedex 09
    Bull Cancer 93:1033-8. 2006
  2. ncbi [Improvement in breast cancer survival between 1975 and 2003 in a cohort of 5722 women]
    Laetitia Huiart
    Département d oncologie génétique, prévention et dépistage, UMR Inserm 599, Institut Paoli Calmettes
    Bull Cancer 93:391-9. 2006
  3. ncbi Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer
    Gilles Houvenaeghel
    Institut Paoli Calmettes, Marseille, France
    J Clin Oncol 24:1814-22. 2006
  4. ncbi Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas
    Olivier Ramuz
    Department of Pathology, Institut Paoli Calmettes, BP 156, 13273 Marseille Cedex 9, France
    Int J Oncol 26:151-7. 2005
  5. ncbi CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    Mohamad Mohty
    Unité de Transplantation et de Thérapie Cellulaire UTTC, Institut Paoli Calmettes, Marseille, France
    Exp Hematol 32:1097-102. 2004
  6. ncbi The benefit of induction chemotherapy in patients age > or = 75 years
    Norbert Vey
    Department of Hematology, Institut Paoli Calmettes, Marseille, France
    Cancer 101:325-31. 2004
  7. ncbi Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma
    Gwenaelle Gravis
    Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France
    Cancer 98:1627-34. 2003
  8. ncbi Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors
    Didier Blaise
    UTTC, Institut Paoli Calmettes, 232 Bd Ste Marguerite, 13273 Marseille Cedex 09, France
    Blood 103:435-41. 2004
  9. ncbi Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Isabelle Brenot-Rossi
    Department of Nuclear Medicine, Institut Paoli Calmettes, Regional Cancer Center, Universite de la Mediterranee, 232 Boulevard Sainte Marguerite, 13273 Marseille Cedex 9, France
    J Nucl Med 44:1232-7. 2003
  10. ncbi Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer
    Valerie Magnin
    Department of Radiotherapy, Institut Paoli Calmettes, Marseille, France
    Int J Radiat Oncol Biol Phys 55:1300-4. 2003

Collaborators

Detail Information

Publications10

  1. ncbi [Impact on the quality of pathology reports in the R2c cancer network: analysis of 4521 pathology reports of primary breast tumors]
    Valerie Jeanne Bardou
    Département d information médicale et biostatistique, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13273 Marseille Cedex 09
    Bull Cancer 93:1033-8. 2006
    ..Lastly, the shared liability in oncology probably has an indirect impact on practices of non-member pathologists...
  2. ncbi [Improvement in breast cancer survival between 1975 and 2003 in a cohort of 5722 women]
    Laetitia Huiart
    Département d oncologie génétique, prévention et dépistage, UMR Inserm 599, Institut Paoli Calmettes
    Bull Cancer 93:391-9. 2006
    ..Taking into account known prognosis factors, survival was significantly improved for recent diagnosis periods (p<0.00001). Observed improvement in survival confirmed 'in real life' data from clinical trials...
  3. ncbi Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer
    Gilles Houvenaeghel
    Institut Paoli Calmettes, Marseille, France
    J Clin Oncol 24:1814-22. 2006
    ..To determine the rate of nonsentinel lymph node (NSN) involvement at axillary lymph node dissection (ALND) and predictive factors of this involvement following detection of micrometastasis in sentinel nodes (SN)...
  4. ncbi Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas
    Olivier Ramuz
    Department of Pathology, Institut Paoli Calmettes, BP 156, 13273 Marseille Cedex 9, France
    Int J Oncol 26:151-7. 2005
    ..Our data suggest that TCL1A immunodetection is an independent marker of adverse outcome that could be used in routine settings for the management of DLCL patients...
  5. ncbi CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    Mohamad Mohty
    Unité de Transplantation et de Thérapie Cellulaire UTTC, Institut Paoli Calmettes, Marseille, France
    Exp Hematol 32:1097-102. 2004
    ..It has been shown that antithymocyte globulin (ATG) dose infused during RIC is a major determinant for the likelihood of developing aGVHD. The ATG modulation on aGVHD is likely related to in vivo T-cell depletion...
  6. ncbi The benefit of induction chemotherapy in patients age > or = 75 years
    Norbert Vey
    Department of Hematology, Institut Paoli Calmettes, Marseille, France
    Cancer 101:325-31. 2004
    ..The authors conducted a retrospective study comparing the outcomes among these elderly patients with the outcomes among younger patients to assess the impact of intensive treatment approaches in this age group...
  7. ncbi Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma
    Gwenaelle Gravis
    Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France
    Cancer 98:1627-34. 2003
    ..The current Phase II study investigated the clinical benefit, impact on quality of life (QOL), and tolerability of weekly docetaxel in symptomatic patients with metastatic hormone-refractory prostate carcinoma (HRPC)...
  8. ncbi Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors
    Didier Blaise
    UTTC, Institut Paoli Calmettes, 232 Bd Ste Marguerite, 13273 Marseille Cedex 09, France
    Blood 103:435-41. 2004
    ..Further studies are warranted in patients with less advanced ST...
  9. ncbi Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Isabelle Brenot-Rossi
    Department of Nuclear Medicine, Institut Paoli Calmettes, Regional Cancer Center, Universite de la Mediterranee, 232 Boulevard Sainte Marguerite, 13273 Marseille Cedex 9, France
    J Nucl Med 44:1232-7. 2003
    ..The aim of this study was to define the factors associated with nonvisualization of a sentinel node (SN) in the axilla area during preoperative lymphoscintigraphy...
  10. ncbi Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer
    Valerie Magnin
    Department of Radiotherapy, Institut Paoli Calmettes, Marseille, France
    Int J Radiat Oncol Biol Phys 55:1300-4. 2003
    ..To assess the toxicity and efficacy of preoperative chemoradiation in pancreatic cancer...